Phio Pharmaceuticals Corp. Contracts & Agreements

142 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
CA
2011
Form of Series I Common Stock Warrant, dated January 17, 2025
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2025
Form of Placement Agent Warrant, dated January 17, 2025
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2025
Form of Securities Purchase Agreement, dated January 16, 2025, by and between the Company and each of the Purchasers signatory thereto
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2025
Form of Series H Common Stock Warrant, dated January 15, 2025
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2025
Form of Placement Agent Warrant, dated January 15, 2025
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2025
Form of Securities Purchase Agreement, dated January 14, 2025, by and between the Company and each of the Purchasers signatory thereto
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2025
Form of Series G Common Stock Warrant, dated January 14, 2025
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2025
Form of Placement Agent Warrant, dated January 14, 2025
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2025
Form of Securities Purchase Agreement, dated January 13, 2025, by and between the Company and each of the Purchasers signatory thereto
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2025
Form of Series F Common Stock Warrant, dated December 24, 2024
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2024
Form of Placement Agent Warrant, dated December 24, 2024
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2024
Form of Securities Purchase Agreement, dated December 23, 2024, by and between the Company and each of the Purchasers signatory thereto
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2024
Form of Series E Common Stock Warrant, dated December 20, 2024
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2024
Form of Placement Agent Warrant, dated December 20, 2024
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2024
Form of Securities Purchase Agreement, dated December 19, 2024, by and between the Company and each of the Purchasers signatory thereto
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2024
Offer Letter, executed July 16, 2024, by and between the Company and Robert M. Infarinato
Phio Pharmaceuticals Corp.
2024
Form of Series C/D Warrant, dated July 12, 2024
Warrant Agreements
Phio Pharmaceuticals Corp.
2024
Form of Placement Agent Warrant, dated July 12, 2024
Warrant Agreements
Phio Pharmaceuticals Corp.
2024
Form of Inducement Letter Agreement, dated July 12, 2024, by and between Phio Pharmaceuticals Corp. and the Holders
Phio Pharmaceuticals Corp.
2024
2020 Phio Pharmaceuticals Corp. Long Term Incentive Plan, as amended and restated
Bonus & Incentive Agreements
Phio Pharmaceuticals Corp.
2024
Purchase Agreement, dated May 16, 2024, by and between Phio Pharmaceuticals Corp. and Triton Funds LP
Purchase Agreements
Phio Pharmaceuticals Corp.
2024
Description of Securities Registered Pursuant to Section 12(b) of the Securities Exchange Act of 1934
Phio Pharmaceuticals Corp.
2024
Form of Series A/B Warrant, dated December 8, 2023
Warrant Agreements
Phio Pharmaceuticals Corp.
2023
Form of Placement Agent Warrant, dated December 8, 2023
Warrant Agreements
Phio Pharmaceuticals Corp.
2023
Form of Inducement Letter Agreement, dated December 6, 2023, by and between Phio Pharmaceuticals Corp. and the Holders
Phio Pharmaceuticals Corp.
2023
2020 Phio Pharmaceuticals Corp. Long Term Incentive Plan, as amended and restated
Bonus & Incentive Agreements
Phio Pharmaceuticals Corp.
2023
Form of Nonqualified Stock Option Award under the Companys 2020 Long Term Incentive Plan
Bonus & Incentive Agreements
Phio Pharmaceuticals Corp.
2023
2020 Phio Pharmaceuticals Corp. Long Term Incentive Plan, as amended and restated
Bonus & Incentive Agreements
Phio Pharmaceuticals Corp.
2023
Form of Series A Common Stock Warrant, dated June 2, 2023
Warrant Agreements
Phio Pharmaceuticals Corp.
2023
Form of Series B Common Stock Warrant, dated June 2, 2023
Warrant Agreements
Phio Pharmaceuticals Corp.
2023
Form of Pre-funded Common Stock Warrant, dated June 2, 2023
Warrant Agreements
Phio Pharmaceuticals Corp.
2023
Form of Securities Purchase Agreement, dated May 31, 2023, by and between the Company and each of the Purchasers signatory thereto (Registered Direct Offering)
Purchase Agreements
Phio Pharmaceuticals Corp.
2023
Form of Securities Purchase Agreement, dated May 31, 2023, by and between the Company and each of the Purchasers signatory thereto (PIPE Private Placement)
Purchase Agreements
Phio Pharmaceuticals Corp.
2023
Form of Registration Rights Agreement, dated May 31, 2023, by and between the Company and each of the Purchasers signatory thereto
Registration Rights Agreements
Phio Pharmaceuticals Corp.
2023
Form of Series A Common Stock Warrant, dated April 20, 2023
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2023
Form of Series B Common Stock Warrant, dated April 20, 2023
Warrant Agreements
Phio Pharmaceuticals Corp.
2023
Form of Existing Warrant Amendment, dated April 18, 2023
Warrant Agreements
Phio Pharmaceuticals Corp.
2023
Form of Securities Purchase Agreement, dated April 18, 2023, by and between the Company and each of the Purchasers signatory thereto
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2023
Clinical Co-development Agreement, dated February 26, 2021, by and between Phio Pharmaceuticals Corp. and AgonOx, Inc
Phio Pharmaceuticals Corp.
2023
Separation Agreement, date May 5, 2022, by and between Phio Pharmaceuticals Corp. and Gerrit Dispersyn, Dr. Med. Sc
Separation Agreements
Phio Pharmaceuticals Corp.
Biotechnology
MA
2023
Employment Agreement, dated February 20, 2023, by and between the Company and Robert J. Bitterman
Employment Agreements
Phio Pharmaceuticals Corp.
2023
Subscription and Investment Representation Agreement, dated November 16, 2022, by and between Phio Pharmaceuticals Corp. and the purchaser signatory thereto
Investment Agreements
Phio Pharmaceuticals Corp.
2022
Form of Restricted Stock Unit Award under the Companys 2020 Long Term Incentive Plan
Bonus & Incentive Agreements
Phio Pharmaceuticals Corp.
2021
Form of Placement Agent Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2021
Form of Securities Purchase Agreement, dated February 12, 2021, by and between the Company and the Purchasers signatory therein
Purchase Agreements
Phio Pharmaceuticals Corp.
2021
Form of Common Stock Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2021
Form of Pre-Funded Common Stock Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
2021
Form of Securities Purchase Agreement, dated January 21, 2021, by and between the Company and the Purchasers signatory therein
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2021
Form of Registration Rights Agreement, dated January 21, 2021, by and between the Company and the Purchasers signatory therein
Registration Rights Agreements
Phio Pharmaceuticals Corp.
2021
Form of Common Stock Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2020
Securities Purchase Agreement, dated March 31, 2020, by and between the Company and the Purchasers signatory therein
Purchase Agreements
Phio Pharmaceuticals Corp.
2020
Description of Securities Registered Pursuant to Section 12(b) of the Securities Exchange Act of 1934
Phio Pharmaceuticals Corp.
2020
Underwriting Agreement, dated as of February 11, 2020, between Phio Pharmaceuticals Corp. and H.C. Wainwright & Co., LLC, as representative of the underwriters named therein
Underwriting Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2020
Form of Common Stock Purchase Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2020
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
2020
Form of Underwriter Common Stock Purchase Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
2020
Form of Common Stock Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
2020
Securities Purchase Agreement, dated February 4, 2020, by and between the Company and the Purchasers signatory therein
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2020
Form of Underwriting Agreement
Underwriting Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2020
Form of Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2020
Form of Pre-Funded Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
2020
Form of Underwriter Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
2020
Placement Agency Agreement, by and between Phio Pharmaceuticals Corp. and H.C. Wainwright & Co., LLC dated as of November 18, 2019
Agency Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2019
Form of Placement Agent Warrants of Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp.
2019
Phio Pharmaceuticals Corp. 2012 Long Term Incentive Plan
Bonus & Incentive Agreements
Phio Pharmaceuticals Corp.
2019
First Amendment to Purchase Agreement by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
IL
2019
Purchase Agreement, dated as of August 7, 2019 by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC
Purchase Agreements
Phio Pharmaceuticals Corp.
2019
Registration Rights Agreement, dated as of August 7, 2019, by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
Phio Pharmaceuticals Corp.
Biotechnology
IL
2019
Employment Agreement, dated April 22, 2019, between Phio Pharmaceuticals Corp. and John A. Barrett, Ph.D
Employment Agreements
Phio Pharmaceuticals Corp.
Biotechnology
MA
2019
Amendment No. 2 to Cauwenbergh Non-Plan Stock Compensation Election Agreement
Stock Agreements
Phio Pharmaceuticals Corp.
2019
First Amendment to Lease Dated January 22, 2019
Lease Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2019
Amendment No. 1 to Cauwenbergh Non-Plan Stock Compensation Election Agreement
Stock Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2018
Underwriting Agreement, dated as of October 1, 2018, between RXi Pharmaceuticals Corporation and H.C. Wainwright & Co., LLC, as representative of the underwriters named therein
Underwriting Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2018
Form of Underwriter Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
2018
Form of Underwriting Agreement
Underwriting Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2018
Form of Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
2018
Form of Pre-Funded Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2018
Non-Plan Stock Compensation Election and Terms and Conditions
Stock Agreements
Phio Pharmaceuticals Corp.
2018
Form of Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
2018
Form of Placement Agent Warrant
Warrant Agreements
Phio Pharmaceuticals Corp.
2018
Securities Purchase Agreement, dated April 9, 2018, by and between the Company and the Purchasers listed therein
Purchase Agreements
Phio Pharmaceuticals Corp.
2018
PURCHASE AGREEMENT
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
IL
2017
PURCHASE AGREEMENT
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
IL
2017
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Phio Pharmaceuticals Corp.
2017
EMPLOYMENT AGREEMENT
Employment Agreements
Phio Pharmaceuticals Corp.
2017
NON-COMPETITION AGREEMENT
Non-Competition Agreements
Phio Pharmaceuticals Corp.
2017
STOCK PURCHASE AGREEMENT
Stock Agreements
Phio Pharmaceuticals Corp.
Biotechnology
DE
2017
2,131,111 SHARES OF COMMON STOCK, 8,082 SHARES OF SERIES B CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO 8,980,000 SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLE FOR 11,111,111...
Underwriting Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2016
SHARES OF COMMON STOCK, SHARES OF SERIES BCONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLE FOR SHARES OFCOMMON STOCK) OF RXi...
Underwriting Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2016
COMMON STOCK PURCHASE WARRANT RXi PHARMACEUTICALS CORPORATION
Warrant Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2016
SHARES OF COMMON STOCK, SHARES OF SERIES BCONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLE FOR SHARES OFCOMMON STOCK) OF RXi...
Underwriting Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2016
COMMON STOCK PURCHASE WARRANT RXi PHARMACEUTICALS CORPORATION
Warrant Agreements
Phio Pharmaceuticals Corp.
2016
OVERALLOTMENT COMMON STOCK PURCHASE RIGHT RXI PHARMACEUTICALS CORPORATION
Stock Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2015
COMMON STOCK PURCHASE WARRANT RXI PHARMACEUTICALS CORPORATION
Warrant Agreements
Phio Pharmaceuticals Corp.
2015
430 Park Avenue | New York, New York 10022 | 212 ###-###-#### | www.hcwco.com Member: FINRA/SIPC 1
Phio Pharmaceuticals Corp.
Biotechnology
2015
RXI PHARMACEUTICALS CORPORATION SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2015
PURCHASE AGREEMENT
Purchase Agreements
Phio Pharmaceuticals Corp.
2014
PURCHASE AGREEMENT
Purchase Agreements
Phio Pharmaceuticals Corp.
2014
MANUFACTURING AND DISTRIBUTION AGREEMENT
Distribution Agreements
Phio Pharmaceuticals Corp.
2014
LEASE AGREEMENT
Lease Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2013
RXI PHARMACEUTICALS CORPORATION 2012 LONG TERM INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Phio Pharmaceuticals Corp.
Biotechnology
DE
2013
RXI PHARMACEUTICALS CORPORATION 2012 LONG TERM INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Phio Pharmaceuticals Corp.
2013
Amendment to RXi Pharmaceuticals Corporation 2012 Incentive Plan
Bonus & Incentive Agreements
Phio Pharmaceuticals Corp.
2013
RXi PHARMACEUTICALS CORPORATION EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2013
ASSET PURCHASE AGREEMENT
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
NY
2013
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Phio Pharmaceuticals Corp.
Biotechnology
DE
2013
LEASE TENANT: RXI PHARMACEUTICALS AND LANDLORD:WESTBOROUGH OFFICE PARK BUILDING FIVE LP 1500 West Park Drive Westborough, Massachusetts TABLE OF CONTENTS
Lease Agreements
Phio Pharmaceuticals Corp.
Biotechnology
MA
2012
SUBLEASE BETWEEN MASSACHUSETTS BIOMEDICAL INITIATIVES, INC. (MBI) AS SUB-LANDLORD AND RXi Pharmaceuticals, Corp. AS SUB-TENANT AT Gateway Park, 60 Prescott Street, Worcester, MA...
Lease Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2012
OMNIBUS AMENDMENT
Phio Pharmaceuticals Corp.
Biotechnology
2012
SECOND OMNIBUS AMENDMENT
Phio Pharmaceuticals Corp.
Biotechnology
2012
THIRD OMNIBUS AMENDMENT
Phio Pharmaceuticals Corp.
2012
FOURTH OMNIBUS AMENDMENT
Phio Pharmaceuticals Corp.
2012
FIFTH OMNIBUS AMENDMENT
Phio Pharmaceuticals Corp.
Biotechnology
2012
SIXTH OMNIBUS AMENDMENT
Phio Pharmaceuticals Corp.
Biotechnology
2012
SEVENTH AMENDMENT AGREEMENT
Phio Pharmaceuticals Corp.
Biotechnology
2012
EMPLOYMENT AGREEMENT
Employment Agreements
Phio Pharmaceuticals Corp.
2012
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
2012
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2012
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2012
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
DE
2012
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
DE
2012
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2012
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
MA
2012
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
DE
2012
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2012
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
DE
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
DE
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
DE
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
CA
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
2011
We are currently working towards filing an investigational new drug application (IND) for RXI-109 and initiating a Phase I/II clinical trial in 2012
Phio Pharmaceuticals Corp.
Biotechnology
2011